BioCentury | Dec 14, 2015
Company News

Miraculins diagnostic news

...is approved in the U.S. and Canada and has CE Mark approval. At Aug. 31, Miraculins...
...had C$7,543 ($5,690) in cash and a nine-month net loss of C$1.9 million ($1.5 million). Miraculins...
BioCentury | Nov 2, 2015
Financial News

Miraculins completes private placement of units

...Units: 2.7 million Price: C$0.05 (unit) Shares after offering: 50.5 million Underwriter: Not disclosed Note: Miraculins...
BioCentury | Jul 20, 2015
Financial News

Miraculins completes private placement of units

Miraculins Inc. (TSX-V:MOM), Winnipeg, Manitoba Business: Diagnostic, Proteomics Date completed: 2015-07-14 Type: Private placement of units Raised: C$350,000 ($274,855) Units: 4.4 million Price: C$0.08 (unit) Shares after offering: 47.8 million Investor: Existing investors Note: Each...
BioCentury | Apr 20, 2015
Financial News

Miraculins completes private placement of units

Miraculins Inc. (TSX-V:MOM), Winnipeg, Manitoba Business: Diagnostic, Proteomics Date completed: 2015-04-10 Type: Private placement of units Raised: C$250,000 ($197,925) Units: 2.5 million Price: C$0.10 (unit) Shares after offering: 41.8 million Note: Each unit comprises a...
BioCentury | Aug 7, 2014
Distillery Techniques

Technology: Assays & screens

...placental growth factor (PGF; PlGF) in ethylenediaminetetraacetic acid (EDTA) anticoagulated plasma samples, to diagnose preeclampsia. Miraculins...
BioCentury | Aug 4, 2014
Financial News

Miraculins completes private placement of units

Miraculins Inc. (TSX-V:MOM), Winnipeg, Manitoba Business: Diagnostic, Proteomics Date completed: 2014-07-30 Type: Private placement of units Raised: C$500,000 ($462,350) Units: 4.5 million Price: C$0.11 (unit) Shares after offering: 20.2 million Note: Each unit comprises a...
BioCentury | Jun 2, 2014
Financial News

Miraculins completes private placement of units

Miraculins Inc. (TSX-V:MOM), Winnipeg, Manitoba Business: Diagnostic, Proteomics Date completed: 5/26/14 Type: Private placement of units Raised: C$260,000 ($238,394) Units: 2.6 million Price: C$0.10 (unit) Shares after offering: 13.3 million Investor: Company director Note: Each...
BioCentury | May 26, 2014
Financial News

Miraculins financial update

...will each receive 500,000 shares in exchange for extending the loans, which bear 12% interest. Miraculins...
...Ross. The loan was due on Oct. 14 and was previously extended from April 12. Miraculins...
...for up to C$1 million from an undisclosed lender. The loan was due Dec. 31. Miraculins...
BioCentury | May 26, 2014
Financial News

Miraculins proposes private placement of units

Miraculins Inc. (TSX-V:MOM), Winnipeg, Manitoba Business: Diagnostic, Proteomics Date announced: 5/21/14 Type: Private placement of units To be raised: Up to C$250,000 ($230,275) Units: 2.5 million Price: C$0.10 (unit) Shares outstanding prior: 13.1 million Note:...
BioCentury | Apr 14, 2014
Financial News

Miraculins proposes private placement of units

Miraculins Inc. (TSX-V:MOM), Winnipeg, Manitoba Business: Diagnostic, Proteomics Date announced: 4/4/14 Type: Private placement of units To be raised: Up to C$500,000 ($455,250) Units: 2 million Price: C$0.25 (unit) Shares outstanding prior: 14.4 million Note:...
Items per page:
1 - 10 of 46
BioCentury | Dec 14, 2015
Company News

Miraculins diagnostic news

...is approved in the U.S. and Canada and has CE Mark approval. At Aug. 31, Miraculins...
...had C$7,543 ($5,690) in cash and a nine-month net loss of C$1.9 million ($1.5 million). Miraculins...
BioCentury | Nov 2, 2015
Financial News

Miraculins completes private placement of units

...Units: 2.7 million Price: C$0.05 (unit) Shares after offering: 50.5 million Underwriter: Not disclosed Note: Miraculins...
BioCentury | Jul 20, 2015
Financial News

Miraculins completes private placement of units

Miraculins Inc. (TSX-V:MOM), Winnipeg, Manitoba Business: Diagnostic, Proteomics Date completed: 2015-07-14 Type: Private placement of units Raised: C$350,000 ($274,855) Units: 4.4 million Price: C$0.08 (unit) Shares after offering: 47.8 million Investor: Existing investors Note: Each...
BioCentury | Apr 20, 2015
Financial News

Miraculins completes private placement of units

Miraculins Inc. (TSX-V:MOM), Winnipeg, Manitoba Business: Diagnostic, Proteomics Date completed: 2015-04-10 Type: Private placement of units Raised: C$250,000 ($197,925) Units: 2.5 million Price: C$0.10 (unit) Shares after offering: 41.8 million Note: Each unit comprises a...
BioCentury | Aug 7, 2014
Distillery Techniques

Technology: Assays & screens

...placental growth factor (PGF; PlGF) in ethylenediaminetetraacetic acid (EDTA) anticoagulated plasma samples, to diagnose preeclampsia. Miraculins...
BioCentury | Aug 4, 2014
Financial News

Miraculins completes private placement of units

Miraculins Inc. (TSX-V:MOM), Winnipeg, Manitoba Business: Diagnostic, Proteomics Date completed: 2014-07-30 Type: Private placement of units Raised: C$500,000 ($462,350) Units: 4.5 million Price: C$0.11 (unit) Shares after offering: 20.2 million Note: Each unit comprises a...
BioCentury | Jun 2, 2014
Financial News

Miraculins completes private placement of units

Miraculins Inc. (TSX-V:MOM), Winnipeg, Manitoba Business: Diagnostic, Proteomics Date completed: 5/26/14 Type: Private placement of units Raised: C$260,000 ($238,394) Units: 2.6 million Price: C$0.10 (unit) Shares after offering: 13.3 million Investor: Company director Note: Each...
BioCentury | May 26, 2014
Financial News

Miraculins financial update

...will each receive 500,000 shares in exchange for extending the loans, which bear 12% interest. Miraculins...
...Ross. The loan was due on Oct. 14 and was previously extended from April 12. Miraculins...
...for up to C$1 million from an undisclosed lender. The loan was due Dec. 31. Miraculins...
BioCentury | May 26, 2014
Financial News

Miraculins proposes private placement of units

Miraculins Inc. (TSX-V:MOM), Winnipeg, Manitoba Business: Diagnostic, Proteomics Date announced: 5/21/14 Type: Private placement of units To be raised: Up to C$250,000 ($230,275) Units: 2.5 million Price: C$0.10 (unit) Shares outstanding prior: 13.1 million Note:...
BioCentury | Apr 14, 2014
Financial News

Miraculins proposes private placement of units

Miraculins Inc. (TSX-V:MOM), Winnipeg, Manitoba Business: Diagnostic, Proteomics Date announced: 4/4/14 Type: Private placement of units To be raised: Up to C$500,000 ($455,250) Units: 2 million Price: C$0.25 (unit) Shares outstanding prior: 14.4 million Note:...
Items per page:
1 - 10 of 46